Plant-based potential in diabetes management: in vitro antioxidant, wound-healing, and enzyme inhibitory activities of southern algarve species

Saraiva de Carvalho, Isabel Maria Marques; Mestre Viegas, Cláudia Sofia; Markiewicz, Marta; Galanty, Agnieszka; Paśko, Paweł; Jakupović, Lejsa; Končić, Marijana Zovko

http://hdl.handle.net/10400.1/27492

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
molecules-30-02432-v2 (1).pdf		884.2 KB	Adobe PDF	Download

Send Feedback

Authors

Saraiva de Carvalho, Isabel Maria Marques

Mestre Viegas, Cláudia Sofia

Končić, Marijana Zovko

Abstract(s)

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by impaired glucose regulation. This study evaluated the antioxidant and antidiabetic potential of aqueous extracts from four plant species from the southern Algarve: Aristolochia baetica, Chelidonium majus, Dittrichia viscosa, and Lavandula viridis, using non-cellular in vitro assays. HPLC/PDA was used to identify active compounds. Antioxidant activity was assessed by using TAA, FRAP, RP, and DPPH assays; antidiabetic potential through alpha-glucosidase and alpha-amylase inhibition; and wound healing relevance through elastase, collagenase, and lipoxygenase inhibition. D. viscosa showed the highest antioxidant activity (FRAP: 1132.99 +/- 19.54 mg TE/g dw; DPPH IC50 = 25.85 +/- 0.75 mu g/mL) and total phenolic/flavonoid content, with a diverse profile including caffeic and chlorogenic acids, isoquercetin, and quercetin. It also exhibited potent alpha-glucosidase inhibition (IC50 = 0.61 +/- 0.06 mg/mL), outperforming acarbose. L. viridis had the highest total phenolic content (39.04 mg/g), while A. baetica demonstrated the strongest anti-elastase, anti-collagenase, and lipoxygenase activity, suggesting wound-healing potential. C. majus showed the weakest effects. A strong correlation was observed between phenolic content and antioxidant/antidiabetic activity. These findings support further in vivo studies on D. viscosa and A. baetica for potential use in T2DM management and diabetic wound healing.